Professional Qualifications

  • Advocaat admitted with the Nederlandse Orde van Advocaten

Recognitions

  • Chambers Europe 2020: “Paul Reeskamp is a great litigator. He possesses the rare ability to adapt strategy even during oral hearings. He is able to listen, and he reflects and – if needed – acts upon advice of the client even under stress.”
  • Legal 500 EMEA 2020: “DLA Piper‘s patent team has strong experience in the biotech, medical devices, oil and gas sectors. It is also well noted for its global network of offices. Key clients include Fresenius Kabi, Smart Technologies Corporation, and Merus. A notable matter highlight includes the representation of Fresenius Kabi in a high-profile patent infringement case against Eli Lilly concerning the generic drug Alimta®. Practice head Paul Reeskamp advised Fresenius Kabi on this matter.”
  • IAM Patent 2019: “Fully lifecycle patent practice is the name of the game at DLA Piper, which thrives in the cut and thrust of litigation and deal negotiation and proficiently handles asset management and restructuring tasks. With veteran litigator Paul Reeskamp and legal director Alexander Tsoutsanis on deck, heavy-duty patent litigation is a forte for the Dutch team, which is currently busy on sundry important cases: Reeskamp is representing Fresenius Kabi in the Dutch and Belgian aspects of its global litigation against Eli Lilly regarding the latter’s blockbuster Alimta Drug.”

Education

  • University of Amsterdam, LL.M., 1985

Memberships

  • EPLAW - European Patent Lawyers Association
  • AIPPI - Member Standing Committee Q222 (Standards and Patents)
  • VIEPA - Dutch association for IP litigation lawyers, Vereniging Intellectuele Eigendom Proces Advocaten
  • WIPO - (World Intellectual Property Organization) domain name arbitration panellist